EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulatory aspects of risks posed by veterinary medicinal products to European necrophagous birds: A case study with nonsteroidal anti-inflammatory drugs (NSAIDs)

Boris Kolar, Nikiforos Alygizakis, Michael G Bertram, Marta Herrero-Villar, Gerd Maack, Gabriele Treu, Mojca Durjava

Environment International · 2026-11 · 217 · 110575

DOI: 10.1016/j.envint.2026.110575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environment International, 2026-11. Verfasst von Boris Kolar und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Laboratory of Health, Environment and Food, Prvomajska 1, 2000 Maribor, Slovenia. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council Formas, Horizon Europe Cluster 1 Health, Horizon Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used in human and veterinary medicine to treat pain and inflammatory diseases. However, the uncontrolled treatment of free-roaming and sheltered livestock with NSAIDs, mainly diclofenac, has caused catastrophic impacts on the biodiversity of necrophagous birds. For instance, a decline of up to 95 % in populations of various species of vultures occurred in South Asia from the late 1990 s to the early 2000 s. In the European context, the European Commission mandated the European Medicines Agency (EMA) to assess the risk posed by diclofenac to necrophagous bird populations in 2014. The risk assessment conducted by the EMA in 2014 identified the risks to affected species. Specific risk-management measures were proposed to facilitate an acceptable level of protection for necrophagous bird populations. Over the last ten years, just one evident death of a necrophagous bird due to intoxication with diclofenac was recorded in Europe. However, the concentrations of different NSAID residues detected in bird carcasses and tissues indicate exposure of avifauna to this group of pharmaceuticals, suggesting that scavenging birds in Europe are not protected against NSAIDs and other veterinary medicines used in animals for human consumption. In addition, NSAIDs are widely used in human medicine and are commonly detected in surface waters of EU member states. We assessed the risk of secondary poisoning based on the detected concentrations of diclofenac in surface waters and identified a risk for piscivorous raptors. We conclude that obligatory risk assessment followed by risk-management measures during the authorisation process does not sufficiently reduce the risk of pharmaceuticals for necrophagous and piscivorous raptors. We propose recommendations and alternative risk-management strategies, underscoring the urgency of protecting European necrophagous and piscivorous raptor populations to sustain the crucial ecosystem services they provide.

Schlagwörter

Stichwörter der Autor:innen

BiodiversityDiclofenacPharmaceuticalPiscivorous raptorsRisk assessmentRisk managementSecondary poisoningVulture conservation

Autor:innen und Institutionen

  • National Laboratory of Health, Environment and Food, Prvomajska 1, 2000 Maribor, Slovenia.
  • Environmental Institute, Okružná 784/42, 972 41 Koš, Slovak Republic.
  • Arthur Rylah Institute for Environmental Research, Department of Energy, Environment and Climate Action, 123 Brown Street, Heidelberg, Victoria 3084, Australia; Department of Wildlife, Fish, and Environmental Studies, S…
  • Institute for Game and Wildlife Research, IREC-CSIC-UCLM-JCCM, Ronda de Toledo s/n, 13071 Ciudad Real, Spain. Electronic address: marta.herrero@uclm.es.
  • Department of Chemicals, German Environment Agency (Umweltbundesamt), Wörlitzer Platz 1, 06813 Dessau-Roßlau, Germany.
  • Department of Chemicals, German Environment Agency (Umweltbundesamt), Wörlitzer Platz 1, 06813 Dessau-Roßlau, Germany; Department of Evolutionary Ecology & Environmental Toxicology, Goethe University Frankfurt, Max-von-…

Förderung

  • Swedish Research Council Formas
  • Horizon Europe Cluster 1 Health
  • Horizon Europe
  • European Cooperation in Science and Technology
  • Swedish University of Agricultural Sciences

Zitieren

APA

Kolar, B., Alygizakis, N., Bertram, M. G., Herrero-Villar, M., Maack, G., Treu, G., & Durjava, M. (2026). Regulatory aspects of risks posed by veterinary medicinal products to European necrophagous birds: A case study with nonsteroidal anti-inflammatory drugs (NSAIDs). Environment International, 217, 110575. https://doi.org/10.1016/j.envint.2026.110575

Vancouver

Kolar B, Alygizakis N, Bertram MG, Herrero-Villar M, Maack G, Treu G, et al. Regulatory aspects of risks posed by veterinary medicinal products to European necrophagous birds: A case study with nonsteroidal anti-inflammatory drugs (NSAIDs). Environment International. 2026;217:110575. doi:10.1016/j.envint.2026.110575

BibTeX
@article{Kolar2026,
  author = {Kolar, Boris and Alygizakis, Nikiforos and Bertram, Michael G and Herrero-Villar, Marta and Maack, Gerd and Treu, Gabriele and Durjava, Mojca},
  title = {Regulatory aspects of risks posed by veterinary medicinal products to European necrophagous birds: A case study with nonsteroidal anti-inflammatory drugs (NSAIDs)},
  journal = {Environment International},
  year = {2026},
  volume = {217},
  pages = {110575},
  doi = {10.1016/j.envint.2026.110575}
}
Kostenlos starten →